Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Boehringer Ingelheim
Harvard Business School

Generated: December 13, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

When do Topiramate patents expire, and what generic alternatives are available?

Topiramate is a drug marketed by Barr, Mylan, Sandoz, Teva, Watson Labs, Zydus Pharms Usa Inc, Accord Hlthcare, Actavis Totowa, Apotex Inc, Aurobindo Pharma, Cipla Ltd, Glenmark Generics, Invagen Pharms, Lupin, Pliva Hrvatska Doo, Roxane, Sun Pharm Inds Ltd, Sun Pharma Global, Torrent Pharms, Unichem Labs Ltd, Upsher-smith Labs, Wockhardt Usa, and Hikma Pharms. and is included in twenty-eight NDAs.

The generic ingredient in TOPIRAMATE is topiramate. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the topiramate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Torrent PharmsTOPIRAMATEtopiramateTABLET;ORAL079153-002Mar 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Invagen PharmsTOPIRAMATEtopiramateTABLET;ORAL079162-002Mar 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cipla LtdTOPIRAMATEtopiramateTABLET;ORAL076343-001Mar 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsTOPIRAMATEtopiramateTABLET;ORAL077643-004Mar 27, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanTOPIRAMATEtopiramateTABLET;ORAL076314-002Mar 27, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdTOPIRAMATEtopiramateTABLET;ORAL076327-001Mar 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LupinTOPIRAMATEtopiramateTABLET;ORAL078410-002Sep 11, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanTOPIRAMATEtopiramateTABLET;ORAL076314-003Mar 27, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pliva Hrvatska DooTOPIRAMATEtopiramateTABLET;ORAL077905-004Mar 30, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma PharmsTOPIRAMATE topiramateTABLET;ORAL091185-001Nov 25, 2013DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Queensland Health
Cantor Fitzgerald
Daiichi Sankyo
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: